CureVac(CVAC) - 2023 Q3 - Earnings Call Presentation

Licensed comparator older adults Phase 1 Study in Glioblastoma Leverages Clinically Validated Shared Antigens CureVac │ Third Quarter and First Nine Months 2023 Results 8 Pmel Dct1) Pbk Trp1 Obsl1 Plod2 Ints11 Kif18b Atp11a Trp53 1 2 3 4 5 6 7 8 9 10 Peptides for restimulation Peptides for restimulation Peptides for restimulation Peptides for restimulation 2) Method: 3 weekly vaccinations, 5 µg intramuscular ▪ Closes small-scale manufacturing gap Formulation module Patents at issue Dec 1, 2010 Jul 27, 2022 ...